Skip to main content
    P

    Protara Therapeutics Inc (TARA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.32
    -0.06 (-2.52%)

    Market Cap: $146.54M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Protara Therapeutics Inc (TARA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Protara Therapeutics (TARA) has a market cap of $146.54M and an enterprise value of $121.39M. Its share count is up 48.68% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 17.16% below the market cap, as cash exceeds debt.

    Market Cap$146.54M
    Enterprise Value$121.39M
    Latest price (Nov 17, 2026)$2.32

    Key Dates

    The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 8, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.02% in the quarter ended Sep 30, 2026 and grew 67.77% a year over 2 years.

    Shares Outstanding62.85M
    Shares Change (YoY)+48.68%
    Shares Change (QoQ)+3.02%
    Share Count Growth (2Y CAGR)+67.77%

    Price Statistics

    The stock is down 57.89% over 52 weeks and trades 18.02% below its 50-day average.

    Beta (1Y)1.32
    52-Week Change-57.89%
    1-Month Change-0.43%
    3-Month Change-41.41%
    6-Month Change-46.54%
    5-Year Change-64.16%
    10-Year Change-99.37%
    Total Return (1Y)-57.89%
    Total Return (3Y CAGR)+26.35%
    Total Return (5Y CAGR)-19.88%
    Return vs SPY (1Y)-77.19%
    Max Drawdown (1Y)-71.83%
    Max Drawdown (3Y)-71.83%
    Sharpe Ratio (1Y)-1.50
    Correlation with SPY (1Y)0.25
    50-Day Average$2.83
    200-Day Average$4.33
    52-Week Range$2.09 to $7.82
    RSI (14 Days)42.2
    Average Volume (20 Days)839.07K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 9.01x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio9.01x
    Quick Ratio9.01x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -55.63% over the last 12 months, against a 5-year average of -41.78%.

    Return on Equity (ROE)-55.63%
    Return on Assets (ROA)-50.11%
    ROE (5Y Average)-41.78%
    ROA (5Y Average)-37.76%
    ROIC (5Y Average)-25.67%

    Scores

    TARA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$93.00K
    Operating Income-$85.19M
    Pretax Income-$78.44M
    Net Income-$78.44M
    Reported EPS (TTM)-$1.40

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 90.09% of the $156.54M in total assets.

    Cash and Equivalents$25.15M
    Total Debt$0
    Net Cash$25.15M
    Net Cash Per Share$0.40
    Working Capital$115.28M
    Shareholder Equity$141.02M
    Book Value Per Share$2.24
    Total Assets$156.54M
    Total Liabilities$15.52M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.08M of capital spending, operating cash flow left -$73.20M of free cash flow.

    Operating Cash Flow-$72.12M
    Capital Expenditures$1.08M
    Free Cash Flow-$73.20M
    FCF Per Share-$1.24
    Depreciation and Amortization$643.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-15.76%
    Tangible Book Per Share Growth (2Y CAGR)-15.76%

    Revenue and profit by year

    Dividends and Yields

    TARA does not pay a dividend. Its free cash flow yield is -50.20%.

    FCF Yield-50.20%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-40 reverse split on Jan 10, 2020.

    Last Split DateJan 10, 2020
    Split TypeReverse split
    Split Ratio1:40

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TARA

    What is TARA's market cap?

    Protara Therapeutics has a market cap of $146.54M. Its enterprise value, which adds debt and subtracts cash, is $121.39M.

    How many shares of TARA are outstanding?

    Protara Therapeutics has 62.85M shares outstanding. The count is up 48.68% from a year earlier.

    Does TARA pay a dividend?

    No. Protara Therapeutics does not pay a dividend.

    How much debt does TARA have?

    Protara Therapeutics has $0 of total debt and $25.15M of cash and equivalents, a net cash position of $25.15M.